These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 6102439)
1. Tardive Dyskinesia: Spotlight on Current Approaches to Treatment. Debrey SM; Goldsmith DR Focus (Am Psychiatr Publ); 2021 Jan; 19(1):14-23. PubMed ID: 34483762 [TBL] [Abstract][Full Text] [Related]
2. Management of Tardive Syndrome: Medications and Surgical Treatments. Factor SA Neurotherapeutics; 2020 Oct; 17(4):1694-1712. PubMed ID: 32720245 [TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia: therapeutic options for an increasingly common disorder. Cloud LJ; Zutshi D; Factor SA Neurotherapeutics; 2014 Jan; 11(1):166-76. PubMed ID: 24310603 [TBL] [Abstract][Full Text] [Related]
4. Intravenous benztropine and propranolol challenges in tardive akathisia. Sachdev P; Loneragan C Psychopharmacology (Berl); 1993; 113(1):119-22. PubMed ID: 7862817 [TBL] [Abstract][Full Text] [Related]
5. Use of propranolol in treating tardive dyskinesia. Einarson TR Can Med Assoc J; 1981 May; 124(10):1260, 1262. PubMed ID: 7237311 [No Abstract] [Full Text] [Related]
6. Brief report: effects of propranolol in Tourette syndrome. Sverd J; Cohen S; Camp JA J Autism Dev Disord; 1983 Jun; 13(2):207-13. PubMed ID: 6345501 [TBL] [Abstract][Full Text] [Related]
7. Serum neuroleptic concentrations and tardive dyskinesia. Jeste DV; Linnoila M; Wagner RL; Wyatt RJ Psychopharmacology (Berl); 1982; 76(4):377-80. PubMed ID: 6126895 [TBL] [Abstract][Full Text] [Related]
8. Use of beta-blocking drugs in psychiatry and neurology. Tyrer PJ Drugs; 1980 Oct; 20(4):300-8. PubMed ID: 6106546 [No Abstract] [Full Text] [Related]
9. [Tardive dyskinesia: etiology, clinical features and therapy]. Furer V; Lichtenberg P; Heresco-Levy U Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354 [No Abstract] [Full Text] [Related]
10. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Barnes TR Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467 [TBL] [Abstract][Full Text] [Related]
11. Low-dose propranolol in tardive dyskinesia. Bacher NM; Lewis HA Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439 [No Abstract] [Full Text] [Related]
12. Propranolol in the treatment of tardive dyskinesia. Perényi A; Farkas A Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627 [No Abstract] [Full Text] [Related]
13. [Improvement of tardive dyskinesia with high doses of propranolol]. Moreira MJ; Karniol IG Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299 [No Abstract] [Full Text] [Related]
14. Propranolol, anxiety, and tardive dyskinesia. Bacher NA; Lewis HA J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849 [No Abstract] [Full Text] [Related]
15. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms. Wilbur R; Kulik FA Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820 [No Abstract] [Full Text] [Related]